[go: up one dir, main page]

Xu et al., 2025 - Google Patents

Role and mechanism of gut microbiota-host interactions in the pathogenesis of Crohn's disease

Xu et al., 2025

View HTML @Full View
Document ID
5199869305812610957
Author
Xu Y
Xie R
Weng Y
Fang Y
Tao S
Zhang H
Chen H
Han A
Jiang Q
Liang W
Publication year
Publication venue
International Journal of Colorectal Disease

External Links

Snippet

Background Crohn's disease (CD) is a chronic, nonspecific inflammatory bowel disease with a poor prognosis. Despite its increasing incidence, curing CD remains challenging due to its complex etiology and unclear pathogenesis. Methods A comprehensive PubMed and Web …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Alshehri et al. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
Bajer et al. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
Shimizu et al. Propionate-producing bacteria in the intestine may associate with skewed responses of IL10-producing regulatory T cells in patients with relapsing polychondritis
Xu et al. 5-Aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis
Suez et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
McIlroy et al. the gut microbiome in inflammatory bowel disease—avenues for microbial management
Angelberger et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation
Tan et al. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis
Sha et al. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children
Gerritsen et al. Intestinal microbiota in human health and disease: the impact of probiotics
Bellocchi et al. Update on the gastrointestinal microbiome in systemic sclerosis
Mizuta et al. Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective, randomized clinical trial
Caenepeel et al. how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease
Mazzawi et al. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels
Qiao et al. Pediococcus acidilactici strains improve constipation symptoms and regulate intestinal flora in mice
Zaccaria et al. Endogenous small intestinal microbiome determinants of transient colonisation efficiency by bacteria from fermented dairy products: a randomised controlled trial
Wang et al. Gut microbiota trajectory in patients with severe burn: A time series study
US20230030056A1 (en) Methods and compositions for treating ulcerative colitis
Ashuro et al. Review on the alteration of gut microbiota: The role of HIV infection and old age
Wang et al. Semi-rational screening of probiotics from the fecal flora of healthy adults against DSS-induced colitis mice by enhancing anti-inflammatory activity and modulating the gut microbiota
Lu et al. Fecal microbiome data distinguish liver recipients with normal and abnormal liver function from healthy controls
Liang et al. Profiles of gut microbiota in children with obesity from Harbin, China and screening of strains with anti‐obesity ability in vitro and in vivo
Landini et al. Microbiota in anorexia nervosa: potential for treatment
Xu et al. Role and mechanism of gut microbiota-host interactions in the pathogenesis of Crohn’s disease
Ellis et al. Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease